Skip to content

Axogen AXGN Debt-to-equity

Debt-to-equity at other companies

Baxter International logo
Baxter InternationalBAX
0.0×
LeMaitre Vascular logo
LeMaitre VascularLMAT
0.1×0.0×
Medtronic logo
MedtronicMDT
0.6×0.0×

Other financials

Income statement

See full
Revenue$61.5M+26.6%
Gross profit$46.2M+32.2%
Operating income-$2.8M-70.5%
Net income-$19.6M-411%
EPS (diluted)-$0.38-375%

Balance sheet

See full
Cash & equivalents$84.7M+251%
Total debt$20.6M-69.8%
Total equity$244.8M+132%
Total assets$289.5M+47.6%

Cash flow

See full
Operating cash flow$1.6M+112%
CapEx$2.8M+989%
Free cash flow-$1.2M+90.9%

Valuation

See full
Market cap$2.38B+110%
Enterprise value$2.31B+91.4%
P/S10×+4.2×

Profitability

See full
Gross margin75%+0.8pp
Operating margin-3.8%
Net margin-13.2%-22.8pp
FCF margin-12.9%-3.8pp

Returns & leverage

See full
Return on equity-18%-70.5pp
Current ratio7.1×+2.8×

Where this comes from

Calculated from Axogen’s reported figures.

Based on the most recent quarter.

The official record: Axogen’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Axogen's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Axogen's debt-to-equity?
Axogen (AXGN) reported debt-to-equity of 0.1× in Q1 2026.
How has Axogen's debt-to-equity changed year-over-year?
Axogen's debt-to-equity decreased by 87.0% year-over-year, from 0.6× to 0.1×.
What is the long-term trend for Axogen's debt-to-equity?
Over 5 years (2020 to 2025), Axogen's debt-to-equity has grown at a 3.7% compound annual growth rate (CAGR), from 0.4× to 0.5×.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.